Cancer Drug Resistance

Published by OAE Publishing Inc.

Open access · United States · Cancer Immunotherapy and Biomarkers

Journal at a glance

ISSN

2578532X

Publisher

OAE Publishing Inc.

Country

United States

Language

en

Also known as: Cancer drug resistance (Alhambra, Calif.) (Alternate title)

Indexing

• Scopus: Indexed
• Pubmed: Active

Metrics

Subjects

• Cancer Immunotherapy and Biomarkers
• Cancer Cells and Metastasis
• Cancer Genomics and Diagnostics
• MicroRNA in disease regulation
• Epigenetics and DNA Methylation
• Cancer, Hypoxia, and Metabolism
• Cancer therapeutics and mechanisms

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• TET2 downregulation limits oxidative stress-induced cytotoxicity of high dose ascorbate in dabrafenib-resistant melanoma cells (2026)
• Mechanistic roles and clinical applications of tertiary lymphoid structures in colorectal cancer drug resistance (2026)
• An epithelial-mesenchymal transition-related gene signature predicts prognosis, immune infiltration, and drug sensitivity in colorectal cancer (2026)
• Lack of resolution of inflammation marks malignant pleural mesothelioma progression (2026)
• LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62–Keap1–Nrf2 pathway (2026)

Similar journals

• Cellular Oncology — Kingdom of the Netherlands · Open access · Same subject: Cancer Cells and Metastasis, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• Trends in Cancer — United States · — · Same subject: Cancer Cells and Metastasis, Same subject: Cancer Genomics and Diagnostics, 4 shared subjects in total, Same country
• Cancer Cell — Kingdom of the Netherlands · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total
• Biochimica et Biophysica Acta - Reviews on Cancer — Kingdom of the Netherlands · — · Same subject: Cancer Cells and Metastasis, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total
• Cancer Discovery — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 3 shared subjects in total, Same country
• Discover Oncology — United States · Open access · Same subject: Cancer Immunotherapy and Biomarkers, Same subject: Cancer, Hypoxia, and Metabolism, 3 shared subjects in total, Same country

Sources: OpenAlex, NLM Catalog, Crossref, Scopus · Last verified 2026-09-05

Journal homepage